Though not quite significant, there were trends towards higher insoluble UFSP2 levels in the temporal cortex of AD patients compared to controls (P=0.050), and towards higher levels of insoluble UFM1 in the temporal cortex of AD patients also approached significance (P=0.062) (Table 1). The gene discussed is UFM1; the disease is Alzheimer disease.